H.B. Fuller (NYSE:FUL – Get Rating) – Investment analysts at Seaport Res Ptn upped their FY2022 earnings per share estimates for shares of H.B. Fuller in a report released on Monday, September 26th. Seaport Res Ptn analyst M. Harrison now forecasts that the specialty chemicals company will post earnings of $4.14 per share for the year, up from their previous estimate of $4.13. The consensus estimate for H.B. Fuller's current full-year earnings is $4.19 per share.
Get H.B. Fuller alerts:H.B. Fuller (NYSE:FUL – Get Rating) last posted its quarterly earnings results on Wednesday, September 21st. The specialty chemicals company reported $1.06 EPS for the quarter, beating the consensus estimate of $1.05 by $0.01. H.B. Fuller had a return on equity of 13.89% and a net margin of 5.33%. The firm had revenue of $941.20 million during the quarter, compared to analysts' expectations of $944.11 million. During the same quarter in the prior year, the firm posted $0.79 EPS. The company's revenue for the quarter was up 13.8% on a year-over-year basis.
A number of other research analysts have also commented on the company. Deutsche Bank Aktiengesellschaft decreased their price objective on H.B. Fuller from $85.00 to $72.00 and set a "buy" rating on the stock in a research report on Friday, June 24th. JPMorgan Chase & Co. cut H.B. Fuller from a "neutral" rating to an "underweight" rating and lowered their target price for the stock from $70.00 to $52.00 in a report on Friday, June 24th. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, H.B. Fuller has an average rating of "Hold" and a consensus price target of $71.00.H.B. Fuller Stock Down 2.2 %
NYSE FUL opened at $60.47 on Thursday. The firm has a market cap of $3.22 billion, a PE ratio of 16.94 and a beta of 1.54. H.B. Fuller has a one year low of $57.36 and a one year high of $81.73. The stock's 50 day simple moving average is $64.81 and its 200 day simple moving average is $65.54. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.93 and a quick ratio of 1.18.
Institutional Trading of H.B. Fuller
A number of institutional investors have recently modified their holdings of the business. Eagle Bay Advisors LLC bought a new stake in H.B. Fuller in the 2nd quarter worth $33,000. Castleview Partners LLC purchased a new position in H.B. Fuller in the fourth quarter worth about $127,000. Russell Investments Group Ltd. raised its holdings in H.B. Fuller by 40.5% in the first quarter. Russell Investments Group Ltd. now owns 5,598 shares of the specialty chemicals company's stock worth $369,000 after buying an additional 1,613 shares during the last quarter. Mutual of America Capital Management LLC raised its holdings in H.B. Fuller by 6.0% in the first quarter. Mutual of America Capital Management LLC now owns 7,613 shares of the specialty chemicals company's stock worth $503,000 after buying an additional 434 shares during the last quarter. Finally, Sciencast Management LP bought a new stake in shares of H.B. Fuller in the second quarter worth approximately $564,000. 96.38% of the stock is currently owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In related news, VP Nathan D. Weaver sold 5,326 shares of the business's stock in a transaction on Thursday, August 11th. The shares were sold at an average price of $66.91, for a total value of $356,362.66. Following the transaction, the vice president now owns 3,354 shares in the company, valued at $224,416.14. The transaction was disclosed in a document filed with the SEC, which is available through this link. In other news, VP Nathan D. Weaver sold 5,326 shares of the company's stock in a transaction dated Thursday, August 11th. The shares were sold at an average price of $66.91, for a total transaction of $356,362.66. Following the transaction, the vice president now owns 3,354 shares in the company, valued at $224,416.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Nathan D. Weaver sold 5,988 shares of the company's stock in a transaction dated Monday, July 25th. The stock was sold at an average price of $62.82, for a total transaction of $376,166.16. Following the completion of the sale, the vice president now owns 3,766 shares in the company, valued at approximately $236,580.12. The disclosure for this sale can be found here. Insiders own 4.69% of the company's stock.
H.B. Fuller Company Profile
(Get Rating)
H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products worldwide. The company operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives.
Featured Articles
- Get a free copy of the StockNews.com research report on H.B. Fuller (FUL)
- Humana Proves Vertically Integrated Healthcare Works
- 2 Casino Stocks Worth Taking a Look At
- This Small-Cap Healthcare Name Is Outperforming Its Index
- What Cintas Can Teach Investors About This Bear Market?
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
Receive News & Ratings for H.B. Fuller Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H.B. Fuller and related companies with MarketBeat.com's FREE daily email newsletter.